Citation 79706

HEGDE,VR: DAI,P: CHU,M: PATEL,M: BRYANT,R: TERRACCIANO,J: DAS,PR: PUAR,MS:. (1997). FERMENTATION, ISOLATION, PHYSICO-CHEMICAL PROPERTIES, STRUCTURE AND BIOLOGICAL ACTIVITY.. 50(12)

Citation Details

Title	FERMENTATION, ISOLATION, PHYSICO-CHEMICAL PROPERTIES, STRUCTURE AND BIOLOGICAL ACTIVITY.
Authors	HEGDE,VR: DAI,P: CHU,M: PATEL,M: BRYANT,R: TERRACCIANO,J: DAS,PR: PUAR,MS:
Year	1997
Volume	50
Issue	12

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Acremonium species (HYPHOMYCETES)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC SCH-60059	None
2	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-60059	ACTIVE
3	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-60059	WEAK ACTIVITY
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC SCH-6005	None
5	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-6005	WEAK ACTIVITY
6	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-6005	WEAK ACTIVITY
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC ACH-64879	None
8	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC ACH-64879	ACTIVE
9	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC ACH-64879	WEAK ACTIVITY
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC ACH-60061	None
11	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC ACH-60061	ACTIVE
12	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC ACH-60061	WEAK ACTIVITY
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC SCH-60063	None
14	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-60063	WEAK ACTIVITY
15	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-60063	WEAK ACTIVITY
16	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC SCH-60057	None
17	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-60057	WEAK ACTIVITY
18	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-60057	WEAK ACTIVITY
19	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ACREMONIUM ANTIBIOTIC SCH-66878	None
20	NEUROKININ NK1 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-66878	ACTIVE
21	NEUROKININ NK2 RECEPTOR ANTAGONIST	PHARMACOLOGY OF COMPOUND - IN VITRO	ACREMONIUM ANTIBIOTIC SCH-66878	WEAK ACTIVITY

Citation 79706

Citation Details

Summary

Organisms and Their Experiments (1)

Acremonium species (HYPHOMYCETES)

Show SPARQL Queries (1)

Query 1